[Federal Register Volume 87, Number 133 (Wednesday, July 13, 2022)]
[Notices]
[Pages 41722-41723]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-14932]



[[Page 41722]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2022-0083]


Advisory Committee to the Director, Centers for Disease Control 
and Prevention

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting of the Advisory Committee to the 
Director, Centers for Disease Control and Prevention (ACD, CDC). This 
is a hybrid meeting, accessible both in person and virtually (webcast 
live via the World Wide Web). It is open to the public and limited only 
by the space available. Time will be available for public comment.

DATES: The meeting will be held on August 9, 2022, from 9:00 a.m. to 
2:30 p.m., EDT (times subject to change).
    Written comments must be received on or before August 1, 2022.

ADDRESSES: 
    Meeting address: CDC Roybal Campus, Building 19, Rooms 247 and 248, 
1600 Clifton Road NE, Atlanta, Georgia 30329-4027. The conference rooms 
combine to accommodate approximately 45 people.
    Please note that the meeting location, the CDC Roybal Campus, is a 
federal facility and in-person access is limited to United States 
citizens unless prior authorizations, taking up to 30 to 60 days, have 
been made. Visitors must follow all directions for access to CDC 
facilities. Directions for visitors to CDC, including COVID-19 
vaccination and testing guidelines, are available at https://www.cdc.gov/screening/visitors.html.
    Registration: You must register to attend this meeting in person. 
If you wish to attend in person, please submit a request by email to 
[email protected] or by telephone at (404) 639-7000 at least 5 
business days in advance of the meeting. No registration is required to 
view the meeting via the World Wide Web. Information for accessing the 
webcast will be available at https://www.cdc.gov/about/advisory-committee-director/.
    Written comments: You may submit comments, identified by Docket No. 
CDC-2022-0083, by either of the methods listed below. Do not submit 
comments for the docket by email. CDC does not accept comments for the 
docket by email.
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: Kerry Caudwell, MPA, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE, Mailstop H21-10, Atlanta, Georgia 
30329-4027. Attn: Docket No. CDC-2022-0083.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov. 
Written comments received in advance of the meeting will be included in 
the official record of the meeting.

FOR FURTHER INFORMATION CONTACT: Kerry Caudwell, MPA, Office of the 
Chief of Staff, Centers for Disease Control and Prevention, 1600 
Clifton Road NE, Mailstop H21-10, Atlanta, Georgia 30329-4027; 
Telephone: (404) 639-7000; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Advisory Committee to the Director, CDC, shall advise 
the Secretary, HHS, and the Director, CDC, on policy and broad 
strategies that will enable CDC to fulfill its mission of protecting 
health through health promotion, prevention, and preparedness. The 
committee recommends ways to prioritize CDC's activities, improve 
results, and address health disparities. It also provides guidance to 
help CDC work more effectively with its various private and public 
sector constituents to make health protection a practical reality.
    Matters To Be Considered: The agenda will include discussions 
regarding CDC's current and future work in the following topic areas: 
(1) data modernization; (2) laboratory quality; and (3) health equity. 
The ACD will hear reports from its working groups on these three 
topics. In addition, the ACD will hear an update on climate change and 
health. Agenda items are subject to change as priorities dictate.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data. Please note that 
comments received, including attachments and other supporting 
materials, are part of the public record and are subject to public 
disclosure. Comments will be posted on https://www.regulations.gov. 
Therefore, do not include any information in your comment or supporting 
materials that you consider confidential or inappropriate for public 
disclosure. If you include your name, contact information, or other 
information that identifies you in the body of your comments, that 
information will be on public display. CDC will review all submissions 
and may choose to redact, or withhold, submissions containing private 
or proprietary information such as Social Security numbers, medical 
information, inappropriate language, or duplicate/near duplicate 
examples of a mass-mail campaign. CDC will carefully consider all 
comments submitted into the docket.
    Oral Public Comment: This meeting will include time for members of 
the public to make an oral comment. Oral public comment will occur 
before any scheduled votes. Priority will be given to individuals who 
submit a request to make an oral public comment before the meeting 
according to the procedure below.
    Procedure for Oral Public Comment: All persons interested in making 
an oral public comment at the August 9, 2022, ACD meeting must submit a 
request by visiting https://www.cdc.gov/about/advisory-committee-director/ no later than 11:59 p.m., EDT, August 1, 2022, according to 
the instructions provided.
    If the number of persons requesting to speak is greater than can be 
reasonably accommodated during the scheduled time, CDC will conduct a 
lottery to determine the speakers for the scheduled public comment 
session. CDC staff will notify individuals regarding their request to 
speak by email by August 3, 2022. To accommodate the significant 
interest in participation in the oral public comment session of ACD 
meetings, each speaker will be limited to 2 minutes, and each speaker 
may only speak once per meeting.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and

[[Page 41723]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-14932 Filed 7-12-22; 8:45 am]
BILLING CODE 4163-18-P